Evidence map›Paper›PMID 40969375›Full record

ReviewFrontiers in endocrinology2025

Rejuvenating the failing heart: multidimensional insights into young blood-mediated anti-aging pathways.

Ming-Tai Chen, Rao-Qiong Wang, Yu-Mei Qian, Ting Peng, Xiao-Yu Lan, Ling-Ling Liang, Gang Luo, Qiu-Yu Liu, Meng-Nan Liu

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ming-Tai Chen *Department of Cardiovascular Disease, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China.
Rao-Qiong Wang *The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
Yu-Mei Qian *The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
Ting PengThe Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
Xiao-Yu LanThe Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
Ling-Ling LiangThe Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
Gang LuoThe Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
Qiu-Yu LiuSchool of Pharmacy, Southwest Medical University, Luzhou, China.
Meng-Nan LiuThe Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF), a serious stage of many cardiovascular illnesses associated with high morbidity and mortality, has emerged a major global public health concern worldwide. Its key pathophysiological mechanisms include cardiac remodeling, neurohormonal dysregulation and cardiac dysfunction. Despite established clinical treatments, adverse reactions and limited efficacy remain problems. In recent years, great emphasis has been paid to young blood, which is defined as blood from young people or in a youth associated physiological condition, and is abundant in various components that help maintain a youthful state of the organism. Currently, some progress has been made in the study of the anti-aging effects and mechanisms of young blood in older individuals, indicating therapeutic potential in the treatment of age-related diseases. In this paper, the major pathophysiological mechanisms of HF, the rejuvenating circulating factors in young blood and their positive effects on aging tissues are summarized. Moreover, the rejuvenating effects of young blood on the failing heart and the possible mechanisms of its action from multiple perspectives are investigated and discussed, aiming to provide theoretical foundation and potential therapeutic targets for the treatment of HF related diseases.

Indexed as

AgingHeart FailureRejuvenationAnimalsHumansanti-aging pathwayscardiac repaircirculating factorsheart failureyoung blood

Identifiers

PMID40969375
PMCPMC12440795

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.